Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

REVIVA PHARMACEUTICALS HOLDINGS, INC.

(RVPH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Certain Stock Options of Reviva Pharmaceuticals Holdings, Inc. are subject to a Lock-Up Agreement Ending on 26-NOV-2021.

11/26/2021 EST

Certain Stock Options of Reviva Pharmaceuticals Holdings, Inc. are subject to a Lock-Up Agreement Ending on 26-NOV-2021. These Stock Options will be under lockup for 184 days starting from 26-MAY-2021 to 26-NOV-2021. Details: The executive officers, directors, and all of the holders of equity securities have entered into a lock up agreement pursuant to which, they will not to offer, sell, contract to sell, pledge, grant any option to purchase, make any short sale or otherwise dispose of, directly or indirectly any shares of common stock or any securities convertible into or exchangeable for common stock, for a period of six months after closing of this offering, without the prior written consent of Maxim Group LLC, on behalf of the underwriters.


ę S&P Capital IQ 2021
All news about REVIVA PHARMACEUTICALS HOLDINGS, INC.
01/26REVIVA PHARMACEUTICALS HOLDINGS, INC : Entry into a Material Definitive Agreement, Financi..
AQ
01/24HC Wainwright Starts Reviva Pharmaceuticals Holdings at Buy With $10 Price Target
MT
01/10Today on Wall Street: More rate hikes expected this year
01/10Reviva Pharmaceuticals Gets FDA Approval to Proceed With Schizophrenia Phase 3 Trial
DJ
01/10Reviva Pharmaceuticals Holdings, Inc. Receives FDA May Proceed Letter for Pivotal Phase..
CI
2021Reviva Pharmaceuticals to Participate in the Upcoming January Virtual Investor Conferen..
GL
2021REVIVA PHARMACEUTICALS HOLDINGS, INC : Submission of Matters to a Vote of Security Holders..
AQ
2021Certain Warrants of Reviva Pharmaceuticals Holdings, Inc. are subject to a Lock-Up Agre..
CI
2021Certain Stock Options of Reviva Pharmaceuticals Holdings, Inc. are subject to a Lock-Up..
CI
2021Certain Common Stock of Reviva Pharmaceuticals Holdings, Inc. are subject to a Lock-Up ..
CI
More news
Analyst Recommendations on REVIVA PHARMACEUTICALS HOLDINGS, INC.
More recommendations
Financials (USD)
Sales 2021 - - -
Net income 2021 -9,16 M - -
Net Debt 2021 - - -
P/E ratio 2021 -2,59x
Yield 2021 -
Capitalization 24,8 M 24,8 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 -
Nbr of Employees 5
Free-Float 61,5%
Chart REVIVA PHARMACEUTICALS HOLDINGS, INC.
Duration : Period :
Reviva Pharmaceuticals Holdings, Inc. Technical Analysis Chart | RVPH | US76152G1004 | MarketScreener
Technical analysis trends REVIVA PHARMACEUTICALS HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 1,64 $
Average target price 12,00 $
Spread / Average Target 632%
EPS Revisions
Managers and Directors
Laxminarayan Bhat President, Chief Executive Officer & Director
Narayan Prabhu Chief Financial Officer
Parag Phoolchand Saxena Chairman
Marcus Cantillon Chief Medical Officer
Richard A. Margolin Independent Director
Sector and Competitors
1st jan.Capi. (M$)
REVIVA PHARMACEUTICALS HOLDINGS, INC.-43.25%25
MODERNA, INC.-37.21%64 657
LONZA GROUP AG-17.41%50 233
IQVIA HOLDINGS INC.-15.35%45 624
SEAGEN INC.-17.45%23 336
ICON PUBLIC LIMITED COMPANY-15.10%21 404